Avergen and BioSolveIT backed by PERMIDES grant for personalized medicine

July 25, 2017 14:29

BioSolveIT and Avergen win a prestigious PERMIDES grant from the European Union to fight against cancer exploiting protein-protein interaction inhibition.

Read the full press release here:
www.biosolveit.de/press/archive/2017-07-25_Avergen.html

Scroll Up